Literature DB >> 24595091

Rheumatoid arthritis: Rheumatoid vasculitis--down but not out.

Richard A Watts1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24595091     DOI： 10.1038/nrrheum.2014.31

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry.

Authors:  X Puéchal; J E Gottenberg; J M Berthelot; L Gossec; O Meyer; J Morel; D Wendling; M de Bandt; E Houvenagel; B Jamard; T Lequerré; G Morel; P Richette; J Sellam; L Guillevin; X Mariette
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

2.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

3.  Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

Authors:  A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

4.  Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.

Authors:  Stephanie J Morris; Mary Chester M Wasko; Jana L Antohe; Jennifer A Sartorius; H Lester Kirchner; Sorina Dancea; Androniki Bili
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

5.  Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years.

Authors:  Christie M Bartels; Carolyn L Bell; Kazuhiko Shinki; Ann Rosenthal; Alan J Bridges
Journal:  Rheumatology (Oxford)       Date:  2010-05-12       Impact factor: 7.580

6.  Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001.

Authors:  Michael M Ward
Journal:  Arthritis Rheum       Date:  2004-04

7.  Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

8.  Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.

Authors:  Eleana Ntatsaki; Janice Mooney; David G I Scott; Richard A Watts
Journal:  Rheumatology (Oxford)       Date:  2013-10-08       Impact factor: 7.580

9.  Vasculitis associated with tumor necrosis factor-α inhibitors.

Authors:  Olayemi Sokumbi; David A Wetter; Ashima Makol; Kenneth J Warrington
Journal:  Mayo Clin Proc       Date:  2012-07-13       Impact factor: 7.616

10.  Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study.

Authors:  Christopher John Edwards; Jennifer Campbell; Tjeerd van Staa; Nigel K Arden
Journal:  BMJ Open       Date:  2012-11-08       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.